Published in Radiother Oncol on February 22, 2017
Radiogenomics and radiotherapy response modeling. Phys Med Biol (2017) 0.75
Radiation-induced lung toxicity in non-small-cell lung cancer: Understanding the interactions of clinical factors and cytokines with the dose-toxicity relationship. Radiother Oncol (2017) 0.75
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol (2006) 6.22
Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med (1994) 5.20
HITON: a novel Markov Blanket algorithm for optimal variable selection. AMIA Annu Symp Proc (2003) 3.32
A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis. Radiother Oncol (2004) 2.36
Receiver operating characteristic analysis: a tool for the quantitative evaluation of observer performance and imaging systems. J Am Coll Radiol (2006) 2.07
Prediction of radiation pneumonitis by dose - volume histogram parameters in lung cancer--a systematic review. Radiother Oncol (2004) 2.00
Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study. Radiother Oncol (2003) 1.97
Predicting the prognosis of breast cancer by integrating clinical and microarray data with Bayesian networks. Bioinformatics (2006) 1.95
Interference with transforming growth factor-beta/ Smad3 signaling results in accelerated healing of wounds in previously irradiated skin. Am J Pathol (2003) 1.64
Cellular basis of radiation-induced fibrosis. Radiother Oncol (1995) 1.52
IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads. J Hepatol (2006) 1.44
Cytokines in radiobiological responses: a review. Radiat Res (2012) 1.29
Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer. Clin Cancer Res (2006) 1.24
Stratification bias in low signal microarray studies. BMC Bioinformatics (2007) 1.16
Genetic variation in the TGF-β signaling pathway and colon and rectal cancer risk. Cancer Epidemiol Biomarkers Prev (2010) 1.15
Predictive markers of radiation pneumonitis. Anticancer Res (2008) 1.10
Morbidity related to axillary irradiation in the treatment of breast cancer. Acta Oncol (2000) 1.09
Cytokine production of lung cancer cell lines: Correlation between their production and the inflammatory/immunological responses both in vivo and in vitro. Cancer Sci (2007) 1.01
Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis. Radiother Oncol (1998) 1.00
Radiation oncology in the era of precision medicine. Nat Rev Cancer (2016) 0.97
TGF-beta 1 inhibition of IFN-gamma-induced signaling and Th1 gene expression in CD4+ T cells is Smad3 independent but MAP kinase dependent. Mol Immunol (2007) 0.93
Nondosimetric risk factors for radiation-induced lung toxicity. Semin Radiat Oncol (2014) 0.88
Bayesian network ensemble as a multivariate strategy to predict radiation pneumonitis risk. Med Phys (2015) 0.87
MicroRNAs, TGF-β signaling, and the inflammatory microenvironment in cancer. Tumour Biol (2015) 0.84
Ipsilateral lung dose volume parameters predict radiation pneumonitis in addition to classical dose volume parameters in locally advanced NSCLC treated with combined modality therapy. South Asian J Cancer (2014) 0.82
Suggestion for a new grading scale for radiation induced pneumonitis based on radiological findings of computerized tomography: correlation with clinical and radiotherapeutic parameters in lung cancer patients. Asian Pac J Cancer Prev (2013) 0.79
Radiation-induced lung damage - Clinical risk profiles and predictive imaging on their way to risk-adapted individualized treatment planning? Radiother Oncol (2015) 0.78